10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $525,649 | -29.3% | 12,743 | -4.3% | 0.00% | 0.0% |
Q2 2023 | $743,230 | +137.5% | 13,310 | +137.3% | 0.00% | 0.0% |
Q1 2023 | $312,926 | +75.9% | 5,609 | +14.9% | 0.00% | – |
Q4 2022 | $177,936 | -52.6% | 4,883 | -62.9% | 0.00% | -100.0% |
Q3 2022 | $375,000 | -42.9% | 13,172 | -9.2% | 0.00% | 0.0% |
Q2 2022 | $657,000 | -11.1% | 14,502 | +49.3% | 0.00% | 0.0% |
Q1 2022 | $739,000 | -28.7% | 9,711 | +39.6% | 0.00% | -50.0% |
Q4 2021 | $1,037,000 | +26.3% | 6,958 | +23.4% | 0.00% | 0.0% |
Q3 2021 | $821,000 | -20.1% | 5,640 | +7.6% | 0.00% | 0.0% |
Q2 2021 | $1,027,000 | +23.6% | 5,243 | +14.2% | 0.00% | 0.0% |
Q1 2021 | $831,000 | +2867.9% | 4,591 | +2195.5% | 0.00% | – |
Q4 2020 | $28,000 | +12.0% | 200 | 0.0% | 0.00% | – |
Q3 2020 | $25,000 | +38.9% | 200 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | -20.0% | 200 | 0.0% | 0.00% | – |
Q4 2019 | $15,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |